ロード中...
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity
Eliciting effective antitumor immune responses in patients who fail checkpoint inhibitor therapy is a critical challenge in cancer immunotherapy, and in such patients, tumor-associated myeloid cells and macrophages (TAMs) are promising therapeutic targets. We demonstrate in an autochthonous, poorly...
保存先:
| 出版年: | J Exp Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Rockefeller University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5839759/ https://ncbi.nlm.nih.gov/pubmed/29436395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20171435 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|